Clinical Documents

To edit the draft, click on the text box below.

×

Draft a comprehensive differential diagnosis for acute substernal chest pain in a 45-year-old male with hypertension and hyperlipidemia, diaphoresis, exertional onset, and normal initial ECG/troponin; include life-threatening causes first, key distinguishing features, and immediate diagnostic next steps.

Draft a detailed differential diagnosis for new-onset unilateral throbbing headache with visual aura and brief monocular vision loss in a 32-year-old female on oral contraceptives; include red-flag symptoms, stroke/TIA considerations, and recommended initial workup.

Draft an assessment and plan for stage-2 hypertension (BP 162/98) in an obese 52-year-old with suspected obstructive sleep apnea; include ASCVD risk estimate, lifestyle prescriptions, first-line pharmacotherapy with drug/dose/targets, baseline labs/monitoring, and 4–6 week follow-up.

Draft an assessment and plan for type 2 diabetes follow-up with A1c 9.2% on metformin 1,000 mg BID and eGFR 65; compare adding a GLP-1 receptor agonist vs an SGLT2 inhibitor, address weight loss goals, hypoglycemia education, vaccinations, and micro/macrovascular screening.

Draft a history and physical for a patient presenting with chest pain, including HPI using OLDCARTS, pertinent ROS, PMH/meds/allergies, FH/SH, focused cardiac/pulmonary exam, initial labs and imaging orders, prioritized differential, HEART score risk stratification, and early management.

Draft a history and physical for a new patient with progressive exertional dyspnea, orthopnea, and bilateral leg edema; include differential (heart failure, COPD, PE, anemia, renal disease), targeted exam maneuvers, and first-line diagnostics and management.

Draft a progress note for COPD follow-up two weeks after an acute exacerbation treated with prednisone and antibiotics; include symptom trajectory, CAT score (if available), inhaler technique/adherence, oxygen needs, spirometry plan, smoking cessation counseling, and return precautions.

Draft a progress note for post-operative day 2 after total knee arthroplasty; include pain control strategy, DVT prophylaxis, PT/OT milestones, wound status, bowel/urinary function, labs/vitals review, complications screening, and discharge readiness.

Draft a discharge summary for community-acquired pneumonia admission; include admission/discharge dates, presenting symptoms, radiology/labs, pathogen if identified, inpatient therapies and response, discharge medications with durations, pending tests, follow-up appointments, and return precautions.

Draft a discharge summary for myocardial infarction managed with PCI and drug-eluting stent placement; include cath findings, complications, inpatient course, discharge medications (DAPT, statin, beta-blocker, ACEi/ARB), cardiac rehab referral, and follow-up plan.

Draft discharge instructions for a patient hospitalized with acute decompensated heart failure; include daily weights, sodium and fluid restriction amounts, medication list with dosing, signs of worsening heart failure, follow-up appointments, and lab monitoring plan.

Draft discharge instructions for an asthma exacerbation; include controller and reliever regimen, steroid taper schedule, spacer technique, trigger avoidance, a written asthma action plan, return precautions, and follow-up timing.

Draft a patient handout on managing high blood pressure in plain language; explain what BP numbers mean, key lifestyle steps (DASH diet, sodium limits, alcohol moderation), home BP monitoring instructions, medication adherence tips, and when to call the doctor.

Draft a patient handout for type 2 diabetes education in plain language; cover A1c goals, the plate method, physical activity targets, self-monitoring of blood glucose, hypoglycemia signs and the 15-15 rule, foot care basics, and a vaccination checklist.

Draft a summary of the latest CDC and WHO guidelines for managing community-acquired pneumonia in adults, including empiric antibiotic choices, duration of therapy, and follow-up recommendations.

Draft a plain-language overview of the ADA and AACE guidelines for diabetes management, focusing on A1c goals, weight management, and the use of GLP-1 receptor agonists and SGLT2 inhibitors.

Draft a summary of the 2024 USPSTF breast cancer screening recommendations, including updated screening intervals, risk-based approaches, and the role of MRI for high-risk patients.

Draft a concise summary of NCCN guidelines for melanoma management, including staging, surgical margins, adjuvant therapy, and checkpoint inhibitor recommendations.

Draft treatment alternatives for community-acquired MRSA skin infections in patients allergic to sulfa drugs; include oral and IV options, dosing, and duration.

Draft treatment alternatives for patients with type 2 diabetes who are unable to tolerate GLP-1 receptor agonists due to nausea; include medication substitutions and lifestyle recommendations.

Draft a summary of options for treating refractory depression, comparing ketamine infusions, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT).

Draft treatment options for advanced prostate cancer, including hormonal therapy, radiopharmaceuticals, and novel androgen receptor pathway inhibitors.

Draft a summary of recent research on mRNA vaccine technology beyond COVID-19, including applications in oncology and autoimmune disease prevention.

Draft an easy-to-understand overview of long COVID research, summarizing major symptoms, hypothesized mechanisms, and emerging treatment approaches.

Draft a summary of current research on Alzheimer’s disease biomarkers, including amyloid and tau imaging, and discuss how they influence diagnosis and trial design.

Draft an explanation of the interaction between warfarin and antibiotics such as ciprofloxacin or TMP-SMX, including INR effects and management recommendations.

Draft a summary evaluating drug interactions for patients taking Paxlovid and common cardiovascular drugs; include mechanism and recommended dose adjustments.

Draft a summary of the common and serious side effects of semaglutide, including GI intolerance, gallbladder disease, and thyroid-related warnings.

Draft an overview of potential side effects associated with long-term corticosteroid use, including osteoporosis, glucose intolerance, and adrenal suppression.

Draft a summary of essential lab tests to order in suspected acute pancreatitis, including amylase, lipase, liver enzymes, and metabolic panels, with interpretation guidance.

Draft laboratory workup recommendations for suspected hypothyroidism, including TSH, free T4, thyroid antibodies, and when to consider secondary causes.

Draft an explanation of which labs should be monitored in patients receiving methotrexate therapy, including CBC, LFTs, renal function, and frequency of monitoring.

why choose us

Edit Geo

×

300×250 Ad Slot

Research Article: Identifying critical windows for macrosomia prevention: a study on the association between phase-specific dynamic BMI changes and macrosomia risk

Date Published: 2026-08-11

Abstract:
To examine the correlation among pre-pregnancy body mass index (BMI), BMI increments during different gestational periods, and the occurrence of macrosomia in singleton full-term pregnant women without complications. Additionally, we aimed to assess the predictive performance of these BMI-related indicators for macrosomia, thereby identifying key time windows for targeted gestational weight management. An analytical approach was adopted, entailing a retrospective evaluation of clinical data from 4,218 pregnant women without complications who underwent regular prenatal examinations and singleton full-term delivery during the period between January 2019 and December 2025 at the Jinshan Branch of Shanghai Sixth People’s Hospital. Based on neonatal birth weight, a case-control design was employed, selecting 200 cases of macrosomia (macrosomia group) and 250 cases of normal birth weight infants (control group). Data including pre-pregnancy BMI, baseline BMI at the first prenatal visit (10–13 weeks), and BMI at various stages of mid- and late-pregnancy (20, 24, 28, 32, 36 weeks, and before delivery) were collected to calculate BMI increments for each stage. The predictive efficacy of individual BMI indicators and a combined model for macrosomia was evaluated using independent sample t-tests, Pearson correlation analysis (PCA), and receiver operating characteristic (ROC) curves. (1) Increased pre-pregnancy BMI was significantly and positively correlated with an increased macrosomia risk. Pre-pregnancy overweight (OR = 2.63) and obesity (OR = 9.06) emerged as independent risk contributors for macrosomia (P < 0.01). (2) Baseline BMI at 10–13 weeks, along with BMI increments during the 32–36 weeks period and the period from 36 weeks to delivery, exhibited a significant increase in the macrosomia group in comparison to the control group (P < 0.05). (3) The analysis of correlation demonstrated a moderate positive correlation between baseline BMI at 10–13 weeks and neonatal birth weight (r = 0.386, P < 0.001). However, no significant correlation was identified between mid-pregnancy BMI increments and birth weight (P > 0.05). (4) Utilising ROC curve analysis, it was ascertained that baseline BMI at 10–13 weeks exhibited the most optimal predictive efficacy among the individual indicators (AUC = 0.73), with the late-pregnancy increment indicators following in succession. The combined predictive model, integrating early-pregnancy BMI and late-pregnancy BMI increments, achieved a superior AUC of 0.84. Pre-pregnancy BMI, early-pregnancy (10–13 weeks) BMI, and late-pregnancy (32 weeks to delivery) BMI increments are critical predictors of macrosomia in pregnant women without complications. Specifically, baseline BMI at 10–13 weeks serves as a core indicator for early risk identification. Clinical interventions should focus on these two critical stages—early and late pregnancy—to implement individualized weight management, thereby effectively reducing the incidence of macrosomia and improving maternal and neonatal outcomes.

Introduction:
Fetal macrosomia is a common adverse obstetric outcome that significantly increases the risk of maternal complications, including shoulder dystocia, severe birth canal lacerations, uterine atony, and postpartum hemorrhage, as well as neonatal birth injuries such as intracranial hemorrhage, clavicular fracture, and brachial plexus injury, thereby posing serious threats to short-term maternal and neonatal health ( 1 ). Consequently, early prediction and precise prevention of macrosomia have become key priorities in…

Read more

300×250 Ad Slot

×
Chat & Ask Questions Career Openings Medical Doctors Check on Drug
Interactions Latest Health News
by WebHealthNetwork Get CME Credits Latest Clinical Trials Latest Research Articles Clinical Documents Update Profile

News

Chat

HCP Tools

Careers

Update Profile